CoChat

Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia

Open access
Dassau, Eyal, Pinsker, Jordan E., Kudva, Yogish C., Brown, Sue A., Gondhalekar, Ravi, Dalla Man, Chiara, Patek, Steve, Schiavon, Michele, Dadlani, Vikash, Dasanayake, Isuru, Church, Mei Mei, Carter, Rickey E., Bevier, Wendy C., Huyett, Lauren M., Hughes, Jonathan, Anderson, Stacey, Lv, Dayu, Schertz, Elaine, Emory, Emma, McCrady-Spitzer, Shelly K., Jean, Tyler, Bradley, Paige K., Hinshaw, Ling, Laguna Sanz, Alejandro J., Basu, Ananda, Kovatchev, Boris, Cobelli, Claudio, Doyle, Francis J. · 2017 · Diabetes Care
Cited by 85

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Artificial pancreas (AP) systems are best positioned for optimal treatment of type 1 diabetes (T1D) and are currently being tested in outpatient clinical trials. Our consortium developed and tested a novel adaptive AP in an outpatient, single-arm, uncontrolled multicenter clinical trial lasting 12 weeks. RESEARCH DESIGN AND METHODS: Thirty adults with T1D completed a continuous glucose monitor (CGM)-augmented 1-week sensor-augmented pump (SAP) period. After the AP was started, basal insulin delivery settings used by the AP for initialization were adapted weekly, and carbohydrate ratios were adapted every 4 weeks by an algorithm running on a cloud-based server, with automatic data upload from devices. Adaptations were reviewed by expert study clinicians and patients. The primary end point was change in hemoglobin A1c (HbA1c). Outcomes are reported adhering to consensus recommendations on reporting of AP trials. RESULTS: Twenty-nine patients completed the trial. HbA1c, 7.0 ± 0.8% at the start of AP use, improved to 6.7 ± 0.6% after 12 weeks (−0.3, 95% CI −0.5 to −0.2, P < 0.001). Compared with the SAP run-in, CGM time spent in the hypoglycemic range improved during the day from 5.0 to 1.9% (−3.1, 95% CI −4.1 to −2.1, P < 0.001) and overnight from 4.1 to 1.1% (−3.1, 95% CI −4.2 to −1.9, P < 0.001). Whereas carbohydrate ratios were adapted to a larger extent initially with minimal changes thereafter, basal insulin was adapted throughout. Approximately 10% of adaptation recommendations were manually overridden. There were no protocol-related serious adverse events. CONCLUSIONS: Use of our novel adaptive AP yielded significant reductions in HbA1c and hypoglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc17-1188

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 85

Metadata

Authors
Dassau, E., Pinsker, J. E., Kudva, Y. C., Brown, S. A., Gondhalekar, R., Dalla Man, C., Patek, S., Schiavon, M., Dadlani, V., Dasanayake, I., Church, M. M., Carter, R. E., Bevier, W. C., Huyett, L. M., Hughes, J., Anderson, S., Lv, D., Schertz, E., Emory, E., McCrady-Spitzer, S. K., Jean, T., Bradley, P. K., Hinshaw, L., Laguna Sanz, A. J., Basu, A., Kovatchev, B., Cobelli, C., & Doyle, F. J.
Venue
Diabetes Care
Published
2017-10-13
Volume
40
Issue
12
Pages
1719-1726
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2763814022
Cited by
85
References
10
FWCI
8.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia. https://app.cochat.ai/papers/10.2337/dc17-1188
The paper
Dassau, E., Pinsker, J. E., Kudva, Y. C., Brown, S. A., Gondhalekar, R., Dalla Man, C., Patek, S., Schiavon, M., Dadlani, V., Dasanayake, I., Church, M. M., Carter, R. E., Bevier, W. C., Huyett, L. M., Hughes, J., Anderson, S., Lv, D., Schertz, E., Emory, E., . . . Doyle, F. J. (2017). Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia. Diabetes Care. https://doi.org/10.2337/dc17-1188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.